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General: IR spectra were recorded on a Bruker Tensor 37 (FTIR) spectrophotometer. 
1
H NMR spectra 
were recorded on Bruker Avance 400 (400 MHz) spectrometer at 295 K in CDCl3; chemical shifts (δ in 
ppm) and coupling constants (J in Hz) are reported in standard fashion with reference to either internal 
standard tetramethylsilane (TMS) (δH = 0.00 ppm) or CHCl3 (δH = 7.25 ppm).  
13
C NMR spectra were 
recorded on Bruker Avance 400 (100 MHz) spectrometer at RT in CDCl3; chemical shifts (δ in ppm) are 
reported relative to CHCl3 (δC = 77.00 ppm). In the 
1
H-NMR, the following abbreviations are used 
throughout: s = singlet, d = doublet, t = triplet, q = quartet, qui = quintet, m = multiplet and br s = broad 




C spectral data.  High-
resolution mass spectra (HR-MS) were recorded on an Agilent 6538 UHD Q-TOF using multimode 
source. Microwave experiments were carried out with CEM Discover Labmate
TM  
instrument in 10 ml 
vial, closed vessel, Power: 250W, Temperature: 60 °C-100 
o
C for 50-100 minutes.  Melting points were 
determined using melting point apparatus manufactured by GUNA enterprises, India and are uncorrected.  
All small scale reactions were carried out using standard syringe-septum technique.  Reactions were 
monitored by TLC on silica gel using a combination of hexane and ethyl acetate as eluents. Solvents were 
distilled prior to use.  
General Procedure for the synthesis of 2-amino-substituted-4(3H)-quinazolinones (5a-5v): 
In an oven dried schlenk tube under argon atmosphere, were added isatoic anhydride (1 equiv, 0.609 
mmol), amine (1 equiv, 0.609 mmol) and activated 4Å molecular sieves (150 mg) followed by addition of 
dry DMSO (2 mL).  The reaction mixture was stirred at 110 
o
C for 30 min to 4 h.  The completion of first 
step was monitored by TLC.  Once dinucleophile was formed Pd(OAc)2  (5 mol%), CyNC (1.5 equiv., 
0.913 mmol) were added in same pot under argon atmosphere.  It was evacuated and filled with O2 by 
using a balloon.  The resulting reaction mixture was heated at 110 
o
C.  Progress of the reaction was 
monitored by TLC, which took 15-17 h.  The reaction mixture was then quenched with water and the 
product was extracted with ethyl acetate.  The organic layer was dried over Na2SO4 and concentrated in 
vacuo.  The crude product  was purified by column chromatography on silica gel using petroleum 
ether/ethyl acetate as eluent, which afforded the desired product (5a-5w).  All the compounds were 




C NMR and HR-MS Spectral analyses.  Among 22 compounds, 











Spectral data of all compounds (5a-5s): 
3-Benzyl-2-(cyclohexylamino)quinazolin-4(3H)-one (5a):
[1]
 White solid (75%),  Mp 106-108 
o
C.  
[TLC control Rf(1) = 0.30, Rf(5a) = 0.70 (petroleum ether/ethyl acetate 8:2, UV detection)]. IR (MIR-
ATR, 4000–600 cm-1): ʋmax = 3324, 3059, 2921, 1627, 1584, 1517, 1487, 1384, 1230, 1198, 1029, 951, 
751, 640. 
 1
H NMR (CDCl3, 400 MHz): δH = 8.18 (dd, 1H, Ja = 8.1 and Jb = 1.2 Hz), 7.60-7.56 (m, 1H), 7.38-7.30 
(m, 4H), 7.29-7.26 (m, 1H), 7.17 (t, 1H, J = 7.6 Hz), 5.32 (s, 2H), 4.36 (d, 1H, J = 6.8 Hz), 3.99-3.91 (m, 
1H), 1.83 (dd, 2H, Ja = 8.6 and Jb = 3.7 Hz), 1.53-1.46 (m, 3H), 1.40-1.29 (m, 2H), 1.18-0.98 (m, 3H).
 13
C 
NMR (CDCl3, 100 MHz): δC = 163.2, 149.5, 149.2, 135.3, 134.4, 129.4, 128.2, 127.4, 126.6, 124.9, 122.4, 
116.9, 49.7, 44.6, 42.5, 25.6, 24.2.  




: 334.1914; found: 334.1901. 
2-(Cyclohexylamino)-3-(4-methoxybenzyl)quinazolin-4(3H)-one (5b): White solid (78%), Mp 130-132 
o
C. [TLC control Rf(1) = 0.30, Rf(5b) = 0.80 (petroleum ether/ethyl acetate 8:2, UV detection)]. 
 IR (MIR-ATR, 4000–600 cm-1): ʋmax = 3421, 2999, 2928, 2852, 1662, 1610, 1578, 1561, 1475, 1450, 
1346, 1247, 1176, 1033, 982, 765, 693. 
 
1
H NMR (CDCl3, 400 MHz): δH = 8.18 (dd, 1H, Ja = 7.8 and Jb = 1 Hz ), 7.60-7.56 (m, 1H), 7.37 (d, 1H, 
J = 8.3 Hz), 7.21 (d, 2H, J = 8.8 Hz), 7.17 (m, 1H), 6.88 (d, 2H, J = 8.3 Hz), 5.26 (s, 2H), 4.44 (d, 1H, J = 
6.8 Hz), 3.99-3.93 (m, 1H), 3.79 (s, 3H), 1.88-1.86 (dd, 2H, Ja = 8.1 and Jb = 3.7 Hz ), 1.54-1.52 (m, 3H), 
1.41-1.32 (m, 2H), 1.20-1.15 (m, 1H), 1.10-1.01 (m, 2H). 
13
C NMR (CDCl3, 100 MHz): δC = 163.4, 
159.7, 149.4, 149.3, 134.3, 127.9, 127.3, 127.2, 124.9, 122.3, 116.9, 114.7, 55.3, 49.7, 44.1, 32.6, 25.6, 
24.3.  




: 364.2020; found: 364.2003. 
2-(Cyclohexylamino)-3-(4-methylbenzyl)quinazolin-4(3H)-one (5c): White solid (78%), Mp 138–140 
o
C. [TLC control Rf(1) = 0.30, Rf(5c) = 0.70 (petroleum ether/ethyl acetate 8:2, UV detection)]. 
IR (MIR-ATR, 4000–600 cm-1): ʋmax = 3422, 2926, 2853, 1659, 1562, 1475, 1346, 1224, 1147, 1069, 986, 
765, 695. 
1
H NMR (CDCl3, 400 MHz): δH = 8.18 (dd, 1H, J = 7.8 Hz), 7.59-7.55 (m, 1H), 7.37 (d, 1H, J = 
8.3 Hz), 7.18-7.16 (m, 5H), 5.28 (s, 2H), 4.4 (d, 1H, J = 6.8 Hz), 3.90-3.99 (m, 1H), 2.33 (s, 3H), 1.80-
1.87 (m, 2H), 1.50 (d, 3H, J = 10.3 Hz), 1.30-1.41 (m, 2H), 1.12-1.19 (m, 1H), 0.99-1.08 (m, 1H).
13
C 
NMR (CDCl3, 100 MHz): δC = 163.2, 149.5, 149.3, 138.0, 134.3, 132.21, 130.0, 127.3, 126.6, 124.9, 
122.4, 116.9, 49.8, 44.4, 32.5, 25.6, 24.2, 21.1. 




: 348.2070; found: 348.2056. 
2-(Cyclohexylamino)-3-(3,4-dimethoxybenzyl)quinazolin-4(3H)-one (5d) : Orange solid (75%), Mp 
100-102 
o
C. [TLC control Rf(1) = 0.30, Rf(5d) = 0.60 (petroleum ether/ethyl acetate 8:2, UV detection)]. 
S4 
 
 IR (MIR-ATR, 4000–600 cm-1): ʋmax = 3413, 2928, 2853, 1667, 1580, 1475, 1380, 1260, 1141, 1027, 
766, 694.  
 1
H NMR (CDCl3, 400 MHz): δH = 8.17 (dd, 1H, Ja = 7.8 and Jb = 1 Hz), 7.59-7.55 (m, 1H), 7.36 (d, 1H, 
J = 8.3 Hz), 7.16 (t, 1H, J = 7.6 Hz), 6.82-6.78 (m, 3H), 5.24 (s, 1H), 4.51 (d, 1H, J = 7.3 Hz), 3.95 (dt, 
1H, Ja = 6.6 and Jb = 3.1 Hz), 3.86 (s, 3H), 3.81 (s, 3H), 1.88-1.85 (m, 2H), 1.53 (d, 3H, J = 8.3 Hz), 
1.37-1.31 (m, 3H), 1.14-1.10 (m, 3H). 
13
C NMR (CDCl3, 100 MHz): δC = 163.2, 149.9, 149.5, 149.4, 
149.0, 134.3, 127.8, 127.3, 124.9, 122.4, 119.0, 116.9, 109.7, 56.0, 55.9, 49.8, 44.6, 32.6, 25.6, 24.8.  




: 394.2125; found: 394.2129. 
2-(Cyclohexylamino)-3-(3-methoxybenzyl)quinazolin-4(3H)-one (5e): White solid (65%), Mp 108–
110 
o
C. [TLC control Rf(1) = 0.30, Rf(5e) = 0.70 (petroleum ether/ethyl acetate 8:2, UV detection)]. 
IR (MIR-ATR, 4000–600 cm-1): ʋmax = 3423, 2969, 2853, 1662, 1579, 1563, 1476, 1347, 1261, 1147, 
1049, 985, 766, 694.  
1
H NMR (CDCl3, 400 MHz): δH = 8.19 (dd, 1H, Ja = 7.8 and Jb = 1.0 Hz), 7.62-7.57 (m, 1H), 7.38 (d, 
1H, J = 8.3 Hz), 7.31-7.27 (m, 1H), 7.18 (t, 1H, J = 7.1 Hz), 6.86 (dd, 2H, Ja = 7.1 and Jb = 4.2 Hz), 6.82 
(s, 1H), 5.30 (s, 2H), 4.41 (d, 1H, J = 6.8 Hz), 3.97 (dd, 1H, Ja = 7.6 and Jb = 4.2 Hz), 3.78 (s, 3H), 1.86 
(dd, 2H, Ja = 8.3 and Jb = 3.9 Hz), 1.55-1.49 (m, 3H), 1.42-1.33 (m, 2H), 1.21-1.15 (m, 1H), 1.10-1.02 
(m, 2H). 
13
C NMR (CDCl3, 100 MHz): δC = 163.1, 160.5, 149.4, 149.2, 136.9, 134.3, 130.4, 127.3, 124.9, 
122.4, 118.9, 116.8, 113.78, 112.2, 55.3, 49.7, 44.6, 32.5, 25.5, 24.2.  
HR-MS (ESI+) m/z calculated for [C22H26N3O2]+ = [M+H]+: 364.2020; found: 364.2003. 
2-(Cyclohexylamino)-3-(4-fluorobenzyl)quinazolin-4(3H)-one (5f): White solid (68%), Mp 118-120 
o
C. [TLC control Rf(1) = 0.30, Rf(5f) = 0.60 (petroleum ether/ethyl acetate 8:2, UV detection)]. 
IR (MIR-ATR, 4000–600 cm-1): ʋmax = 3435, 2930, 2854, 1659, 1557, 750, 663. 
1
H NMR (CDCl3, 400 MHz): δH = 8.17 (dd, 1H, Ja= 8.1 and Jb = 1.2 Hz), 7.61-7.57 (m, 1H), 7.38 (d, 1H, 
J = 7.38 Hz), 7.20-7.16 (m, 1H), 7.06 (t, 2H, J = 8.6 Hz), 5.29 (s, 2H), 4.27 (d, 1H, J = 7.3 Hz), 4.00-3.94 
(m, 1H), 1.90-1.86 (m, 2H), 1.52 (d, 3H, J = 10.3 Hz), 1.42-1.33 (m, 2H), 1.18-1.14 (m, 1H), 1.08-1.00 
(m, 2H). 
13
C NMR (CDCl3, 100 MHz): δC = 163.7, 163.1, 161.3, 149.4, 148.9, 134.5, 131.1, 131.0, 128.4, 
128.3, 127.3, 125.0, 122.5, 116.8, 116.4, 116.2, 49.8, 43.9, 32.6, 25.6, 24.3.  




: 352.1820; found: 352.1804. 
3-(2-Chlorobenzyl)-2-(cyclohexylamino)quinazolin-4(3H)-one (5g): White solid (72%), Mp 108-110 
o
C. [TLC control Rf(1) = 0.30, Rf(5g) = 0.70 (petroleum ether/ethyl acetate 8:2, UV detection)]. 
IR (MIR-ATR, 4000–600 cm-1): ʋmax = 3386, 2927, 2854, 1656, 1558, 1472, 1344, 1215, 1065, 830, 755, 
663. 
1
H NMR (CDCl3, 400 MHz): δH  = 8.08-8.06 (m, 1H), 7.51-7.47 (m, 1H), 7.30 (dd, 2H, Ja= 16.9 and Jb = 
8.1 Hz), 7.16-7.11 (m, 1H), 7.09-7.04 (m, 3H), 5.34 (s, 2H), 4.28 (d, 1H, J = 7.3 Hz), 3.89 (dtd, 1H, Ja = 





C NMR (CDCl3, 100 MHz): δC = 163.2, 149.5, 148.5, 134.5, 132.6, 132.4, 129.6, 129.4, 128.2, 
127.9, 127.3, 125.0, 122.4, 116.7, 50.1, 41.1, 32.7, 25.6, 24.5. 




: 368.1524; found: 368.1509. 
3-(2-(1H-indol-2-yl)ethyl)-2-(cyclohexylamino)quinazolin-4(3H)-one (5h): Yellow solid (62%), Mp 
108-110 
o
C. [TLC control Rf(1) = 0.30, Rf(5h) = 0.50 (petroleum ether/ethyl acetate 8:2, UV detection)]. 
 IR (MIR-ATR, 4000–600 cm-1): ʋmax = 3381, 2928, 2853, 1653, 1562, 1349, 1248, 1147, 1011, 891, 741, 
663.  
1
H NMR (CDCl3, 400 MHz): δH = 8.40 (br s, 1H), 8.02 (d, 1H, J = 8.3 Hz), 7.54 (d, 1H, J = 7.3 Hz), 7.43-
7.39 (m, 1H), 7.26 (d, 1H, J = 7.8 Hz), 7.18 (d, 1H, J = 8.3 Hz), 7.13-7.09 (m, 1H), 7.07-6.99 (m, 2H), 
6.77 (s, 1H), 4.17 (t, 2H, J = 6.1 Hz), 3.61 (d, 1H, J = 7.3 Hz), 3.44-3.41 (m, 1H), 3.15 (t, 2H, J = 6.1 Hz), 
1.44-1.33 (m, 6H), 1.16-0.99 (m, 3H), 0.80-0.74 (m, 1H). 
13
C NMR (CDCl3, 100 MHz): δC = 163.3, 
149.6, 149.3, 136.7, 134.2, 126.8, 126.6, 124.8, 123.2, 122.8, 120.2, 118.0, 117.1, 111.9, 111.8, 49.7, 
43.5, 31.9, 25.5, 24.8, 24.1. 




: 387.2179; found: 387.2162. 
3-Benzyl-2-(tert-butylamino)quinazolin-4(3H)-one (5i):
[1]
 White solid (40%), Mp 110–112 oC. [TLC 
control Rf(1) = 0.30, Rf(5i) = 0.60 (petroleum ether/ethyl acetate 8:2, UV detection)]. 
IR (MIR-ATR, 4000–600 cm-1): ʋmax = 3435, 3032, 2961, 2925, 1672, 1584, 1567, 1477, 1362, 1208, 
1148, 976, 766, 695. 
1
H NMR (CDCl3, 400 MHz): δH = 8.18 (dd, 1H, Ja = 8.1 and Jb = 1.2 Hz), 7.58-7.56 (m, 1H), 7.38-7.31 
(m, 4H), 7.26 (d, 2H, J = 7.3 Hz), 7.19-7.15 (m, 1H), 5.3 (s, 2H), 4.32 (s, 1H), 1.32 (s, 9H). 
13
C NMR 
(CDCl3, 100 MHz): δC = 163.3, 149.1, 148.4, 135.5, 134.2, 129.3, 128.2, 127.3, 126.7, 125.3, 122.4, 
116.9, 52.6, 44.9, 28.8.  




: 308.1757; found: 308.1744. 
2-(Tert-butylamino)-3-cyclohexylquinazolin-4(3H)-one (5j): White solid (32%), Mp 82–84 oC. [TLC 
control Rf(1) = 0.30, Rf(5j) = 0.60 (petroleum ether/ethyl acetate 8:2, UV detection)]. 
 IR (MIR-ATR, 4000–600 cm-1): ʋmax = 3496, 2930, 2856, 1669, 1568, 1519, 1478, 1361, 1205, 1137, 
953, 764, 697.  
1
H NMR (CDCl3, 400 MHz): δH = 8.07 (dd, 1H, Ja = 8.2 and Jb = 1.2Hz), 7.54-7.50 (m, 1H), 7.34-7.26 
(m, 1H), 7.12-7.08 (m, 1H), 5.14 (br s, 1H), 4.6 (br s, 1H), 2.16-2.04 (m, 2H), 1.94-1.70 (m, 6H), 1.60-
1.42 (m, 2H). 
13
C NMR (CDCl3, 100 MHz): δC = 163.5, 148.7, 148.3, 133.9, 127.1, 124.8, 122.1, 52.6, 
30.4, 29.3, 26.6, 25.7.  




: 300.2070; found: 300.2057. 
3-(2-Bromophenyl)-2-(cyclohexylamino)quinazolin-4(3H)-one (5k): White solid (48%), Mp 162-164 
o
C. [TLC control Rf(1) = 0.30, Rf(5k) = 0.50 (petroleum ether/ethyl acetate 8:2, UV detection)]. 
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IR (MIR-ATR, 4000–600 cm-1): ʋmax = 3288, 2920, 2851, 1735, 1631, 1602, 1567, 1474, 1329, 1231, 
1119, 1020, 957, 758, 648.  
1
H NMR (CDCl3, 400 MHz): δH = 8.13 (dd, 1H, Ja = 7.8 and Jb =1 Hz), 7.82 (dd, 1H, Ja = 8.1 and Jb = 1.2 
Hz), 7.63-7.59 (m, 1H), 7.56-7.52 (m, 1H), 7.44-7.37 (m, 3H), 7.18-7.14 (m, 1H), 4.07-4.02 (m, 1H), 3.71 
(d, 1H, J = 7.3Hz), 2.04-1.92 (m, 2H), 1.70-1.57 (m, 3H), 1.45-1.31 (m, 3H), 1.18-1.02 (m, 2H).
 13
C 
NMR (CDCl3, 100 MHz): δC = 162.0, 149.8, 147.9, 134.7, 134.5, 134.3, 131.4, 130.9, 129.5, 127.3, 125.0, 
123.6, 122.4, 117.4, 49.8, 32.9, 32.8, 29.7, 28.8, 26.4, 25.6, 24.6, 24.5. 




: 398.0863; found: 398.0879. 
2-(Cyclohexylamino)-3-phenylquinazolin-4(3H)-one (5l): White solid (35%), Mp 158–160 oC. [TLC 
control Rf(1) = 0.30, Rf(5l) = 0.80 (petroleum ether/ethyl acetate 8:2, UV detection)]. 
IR (MIR-ATR, 4000–600 cm-1): ʋmax = 3291, 2921, 2853, 1740, 1601, 1475, 1049, 759, 686. 
1
H NMR (CDCl3, 400 MHz): δH = 8.01 (dd, 1H, Ja = 8.1 and Jb =1.2 Hz), 7.69-7.58 (m, 2H), 7.42-7.23 
(m, 2H), 7.14 (m, 1H), 4.90 (br s, 1H), 3.81 (m, 1H), 2.06 (dd, 1H, Ja = 12.2 and Jb = 2.9 Hz), 1.77-1.72 
(m, 3H), 1.65-1.61 (m, 1H), 1.48-1.37 (m, 2H), 1.30-1.18 (m, 3H). 
13
C NMR (CDCl3, 100 MHz): δC = 
160.1, 150.6, 136.6, 128.7, 124.2, 123.4, 119.9, 113.2, 50.2, 32.9, 25.4, 24.6.  




: 320.1757; found: 320.1739.  
3-Benzyl-6-chloro-2-(cyclohexylamino)quinazolin-4(3H)-one (5m):
[1]
 White solid (75%), Mp 124-126 
o
C. [TLC control Rf(1) = 0.30, Rf(5m) = 0.70 (petroleum ether/ethyl acetate 8:2, UV detection)]. 
IR (MIR-ATR, 4000–600 cm-1): ʋmax = 3324, 3059, 2921, 1627, 1584, 1384, 1230, 1198, 1065, 951, 756, 
640.  
1
H NMR (CDCl3, 400 MHz): δH = 8.13 (d, 1H, J = 2.4 HZ), 7.5 (dd, 1H, Ja = 8.8 and Jb = 2.4 Hz), 7.38-
7.24 (m, 6H), 5.3 (s, 1H), 4.39 (d, 1H, J = 7.3 Hz), 3.93-3.90 (m, 1H), 1.81 (dd, 2H, Ja = 8.6 and Jb = 3.7 
Hz), 1.53-1.46 (m, 3H), 1.37-1.28 (m, 4H), 1.05-0.97 (m, 2H). 
13
C NMR (CDCl3, 100 MHz): δC = 162.2, 
149.3, 148.1, 135.0, 134.6, 129.5, 128.4, 127.6, 126.7, 126.6, 126.5, 117.7, 49.8, 44.7, 32.5, 29.7, 25.5, 
24.2. 




: 368.1524; found: 365.1518. 
6-chloro-2-(Cyclohexylamino)-3-(4-methoxybenzyl)quinazolin-4(3H)-one (5n): White solid (72%), 
Mp 98-100 
o
C. [TLC control Rf(1) = 0.30, Rf(5n) = 0.70 (petroleum ether/ethyl acetate 8:2, UV 
detection)]. 
IR (MIR-ATR, 4000–600 cm-1): ʋmax = 3321, 3057, 2921, 1629, 1574, 1517, 1482, 1381, 1230, 1247, 
1188, 1025, 951, 761, 643. 
1
H NMR (CDCl3, 400 MHz): δH = 8.12 (d, 1H, J = 2.4 Hz), 7.48 (dd, 1H, Ja = 8.8 and Jb = 2.4 Hz), 7.30-
7.26 (m, 1H), 7.19 (d, 2H, J = 8.3 Hz), 6.88 (d, 2H, J = 8.8 Hz), 5.22 (s, 2H), 4.47 (d, 1H, J = 6.8 Hz), 
3.93-3.89 (m, 1H), 3.78 (s, 3H), 1.85 (dd, 2H, Ja = 8.3 and Jb = 3.9 Hz), 1.53-1.51 (m, 3H), 1.39-1.29 (m, 
S7 
 
3H), 1.08-0.99 (m, 2H).
 13
C NMR (CDCl3, 100 MHz): δC =  162.2, 159.6, 149.4, 148.0, 134.6, 128.0, 
127.8, 126.6, 126.5, 117.8, 114.8, 55.4, 49.9, 44.3, 32.6, 29.8, 25.5, 24.3.  




: 398.1630; found: 398.1628.  
6-Chloro-2-(Cyclohexylamino)-3-(4-methylbenzyl)quinazolin-4(3H)-one (5o): White solid (70%), Mp 
136-138 
o
C. [TLC control Rf(1) = 0.30, Rf(5o) = 0.60 (petroleum ether/ethyl acetate 8:2, UV detection)]. 




H NMR (CDCl3, 400 MHz): δH = 8.13 (d, 1H, J = 2.4 Hz), 7.50-7.48 (m, 1H), 7.30-7.26 (m, 1H), 7.17-
7.12 (m, 5H), 5.25 (s, 2H), 4.44 (d, 1H, J = 6.8 Hz), 3.91 (dt, 1H, Ja = 6.6 and Jb = 3.1 Hz), 2.33 (s, 3H), 
1.33 (dd, 2H, Ja = 8.6 and Jb = 3.7 Hz), 1.5 (d, 4H, J = 10.3 Hz), 1.39-1.29 (m, 2H), 1.18-1.13 (m, 1H), 
1.07-1.00 (m, 2H). 
13
C NMR (CDCl3, 100 MHz): δC = 162.2, 149.4, 148.1, 138.2, 134.6, 131.8, 130.1, 
127.5, 126.6, 126.5, 126.4, 117.7, 117.8, 49.9, 44.6, 32.5, 25.5, 24.2, 21.1.  




: 382.1681; found: 398.1680.  
6-Chloro-2-(Cyclohexylamino)-3-(3,4-dimethoxybenzyl)quinazolin-4(3H)-one (5p) : White solid 
(72%), Mp 124-126 
o
C. [TLC control Rf(1) = 0.30, Rf(5p) = 0.60 (petroleum ether/ethyl acetate 8:2, UV 
detection)]. 
  IR (MIR-ATR, 4000–600 cm-1): ʋmax = 3416, 3018, 2932, 2855, 1665, 1561, 1473, 1260, 1214, 1140, 
1025, 746, 664. 
1
H NMR (CDCl3, 400 MHz): δH = 8.1 (d, 1H, J = 2.4 Hz), 7.47 (dd, 1H, Ja = 8.8 and Jb = 2.4 Hz), 7.29-
7.26 (m, 1H), 6.83-6.76 (m, 3H), 5.21 (s, 2H), 4.56 (d, 1H, J =6.8 Hz), 3.94-3.87 (m, 1H), 3.85 (s, 3H), 
3.80 (s, 3H), 1.85 (d, 2H, J = 8.8 Hz), 1.53 (d, 3H, J = 8.3 Hz), 1.39-1.30 (m, 2H), 1.23-1.00 (m, 3H).  
13
C NMR (CDCl3, 100 MHz): δC = 162.3, 150.0, 149.5, 149.1, 148.1, 134.6, 127.5, 126.6, 126.5, 119.0, 
117.7, 111.5, 109.7, 56.0, 55.9, 49.9, 44.7, 32.6, 25.5, 24.5. 




: 428.1735; found: 428.1735.  
6-Chloro-2-(Cyclohexylamino)-3-(4-fluorobenzyl)quinazolin-4(3H)-one (5q): White solid (68%), Mp 
124-126 
o
C. [TLC control Rf(1) = 0.30, Rf(5q) = 0.70 (petroleum ether/ethyl acetate 8:2, UV detection)]. 
 IR (MIR-ATR, 4000–600 cm-1): ʋmax = 3435, 2930, 2854, 1659, 1557, 1310, 1129, 1066, 894, 750, 663. 
 1
H NMR (CDCl3, 400 MHz): δH =  8.1 (d, 1H, J = 2.4 Hz), 7.50-7.48 (m, 1H), 7.30 (d, 1H, J = 8.8 Hz), 
7.26-7.21 (m, 2H), 7.05 (t, 2H, J = 8.6 Hz), 5.25 (s, 2H), 4.32 (d, 1H, J = 6.8 Hz), 3.96-3.89 (m, 1H), 1.86 
(dd, 3H, Ja = 12.0 and Jb = 3.2 Hz), 1.52 (dd, 3H, Ja = 9.0 and Jb = 4.4 Hz), 1.41-1.30 (m, 2H), 1.19-1.13 
(m, 1H), 1.07-0.98 (m, 2H).
 13
C NMR (CDCl3, 100 MHz): δC = 163.8, 162.1, 149.0, 148.0, 134.7, 130.8, 
130.7, 128.4, 128.3, 127.6, 126.7, 126.4, 117.6, 116.5, 116.3, 50.0, 44.0, 32.6, 25.5, 24.3.  




: 386.1430; found: 386.1431. 
S8 
 
6-chloro-3-(2-Chlorobenzyl)-2-(cyclohexylamino)quinazolin-4(3H)-one (5r): White solid (72%), Mp 
120-122 
o
C. [TLC control Rf(1) = 0.30, Rf(5r) = 0.50 (petroleum ether/ethyl acetate 8:2, UV detection)]. 
IR (MIR-ATR, 4000–600 cm-1): ʋmax = 3431, 2923, 2852, 1672, 1559, 1472, 1329, 1135, 1033, 824, 745, 
622. 
1
H NMR (CDCl3, 400 MHz): δH = 8.12 (d, 1H, J = 2 Hz), 7.51 (dd, 1H, Ja = 8.8 and Jb = 2.4 Hz), 7.43 (d, 
1H, J = 7.8 Hz), 7.31-7.26 (m, 2H), 7.24-7.19 (m, 2H), 7.13-7.11 (m, 1H), 5.42 (s, 2H), 4.42 (d, 1H, J = 
6.8 Hz), 3.95 (dtd, 1H, Ja = 10.1, Jb = 6.1 and Jc = 3.9 Hz), 1.89-1.86 (m, 2H), 1.57 (d, 3H, J = 8.3 Hz), 
1.40-1.30 (m, 2H), 1.19-1.04 (m, 3H). 
13
C NMR (CDCl3, 100 MHz): δC = 162.3, 148.6, 134.8, 132.4, 
132.3, 129.7, 129.5, 128.2, 128.0, 127.6, 126.7, 126.5, 117.5, 50.2, 41.2, 32.6, 25.5, 24.5.  




: 402.1134; found: 402.1134. 
6-Chloro-3-(2-(1H-indol-2-yl)ethyl)-2-(cyclohexylamino)quinazolin-4(3H)-one (5s): Pale yellow 
(62%), Mp 142-144 
o
C. [TLC control Rf(1) = 0.30, Rf(5m) = 0.50 (petroleum ether/ethyl acetate 8:2, UV 
detection)]. 
 IR (MIR-ATR, 4000–600 cm-1): ʋmax = 3443, 3373, 2928, 2854, 1669, 1558, 1473, 1344, 1217, 1131, 
1067, 896, 749, 662.  
 
1
H NMR (CDCl3, 400 MHz): δH = 8.28 (br s, 1H), 8.08 (d, 1H, J = 2.4 Hz), 7.65 (d, 1H, J = 7.8 Hz), 
7.45-7.38 (m, 2H), 7.26-7.15 (m, 3H), 6.91 (d, 1H, J = 2Hz), 4.26 (t, 2H, J = 6.1 Hz), 3.74 (d, 1H, J = 7.3 
Hz), 3.5 (dtt, 1H, Ja = 10.9, Jb = 7.1 and Jc = 3.6 Hz), 3.26 (t, 2H, J = 6.1 Hz), 1.52-1.41 (m, 5H), 1.26-
1.09 (m, 4H).
 13
C NMR (CDCl3, 100 MHz): δC = 162.2, 149.3, 147.9, 136.7, 134.4, 127.3, 126.5, 126.0, 
123.1, 122.9, 120.4, 118.0, 117.9, 112.0, 111.9,49.8, 43.6, 31.9, 25.5, 24.8, 24.1. 



























C NMR spectra of all compounds (5a-5s) 
 




















































































































































H NMR (400MHz) spectrum of compound 5a in CDCl3 
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C NMR (100MHz) spectrum of compound 5a in CDCl3. 






















































































































H NMR (400MHz) spectrum of compound 5b in CDCl3 
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C NMR (100MHz) spectrum of compound 5b in CDCl3. 




































































































































































H NMR (400MHz) spectrum of compound 5c in CDCl3. 
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C NMR (100MHz) spectrum of compound 5c in CDCl3. 

















































































































































































































H NMR (400MHz) spectrum of compound 5d in CDCl3. 
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C NMR (100MHz) spectrum of compound 5d in CDCl3. 
















































































































H NMR (400MHz) spectrum of compound 5e in CDCl3. 
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C NMR (100MHz) spectrum of compound 5e in CDCl3. 
 













































































































H NMR (400MHz) spectrum of compound 5f in CDCl3. 
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C NMR (100MHz) spectrum of compound 5f in CDCl3. 
 










































































































H NMR (400MHz) spectrum of compound 5g in CDCl3. 
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C NMR (100MHz) spectrum of compound 5g in CDCl3. 
 































































































































H NMR (400MHz) spectrum of compound 5h in CDCl3. 
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C NMR (100MHz) spectrum of compound 5h in CDCl3. 











































































































































H NMR (400MHz) spectrum of compound 5i in CDCl3. 
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H NMR (400MHz) spectrum of compound 5j in CDCl3. 























































C NMR (100MHz) spectrum of compound 5j in CDCl3. 
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H NMR (400MHz) spectrum of compound 5k in CDCl3. 



















































































































































































C NMR (100MHz) spectrum of compound 5k in CDCl3. 
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H NMR (400MHz) spectrum of compound 5l in CDCl3. 



















































































































C NMR (100MHz) spectrum of compound 5l in CDCl3. 
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H NMR (400MHz) spectrum of compound 5m in CDCl3. 
 




































































































































































































































































H NMR (400MHz) spectrum of compound 5n in CDCl3. 
 

















































































































C NMR (100MHz) spectrum of compound 5n in CDCl3. 
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H NMR (400MHz) spectrum of compound 5o in CDCl3. 
 












































































































C NMR (100MHz) spectrum of compound 5o in CDCl3. 
S25 
 





























































































































































H NMR (400MHz) spectrum of compound 5p in CDCl3. 
















































































































































































































































































H NMR (400MHz) spectrum of compound 5q in CDCl3. 
 
































































































































C NMR (100MHz) spectrum of compound 5q in CDCl3. 
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H NMR (400MHz) spectrum of compound 5r in CDCl3. 






















































































































































































































































































































H NMR (400MHz) spectrum of compound 5s in CDCl3 
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